PMID: 8977545Dec 1, 1996Paper

Risk management in allergen immunotherapy

The Journal of Allergy and Clinical Immunology
D K Greineder

Abstract

The major risk of allergen immunotherapy is the development of systemic anaphylactic reactions. The reported frequency of systemic reactions after allergen immunotherapy varies from < 1% in patients receiving conventional immunotherapy to > 36% in patients receiving rush immunotherapy. Fatal and systemic reactions to allergen immunotherapy have similar characteristics. The onset of both types of reaction occurs < 30 minutes after injection in approximately 70% of patients. The most common risk factors for fatal and systemic reactions to allergen immunotherapy include a history of asthma, increasing allergen dose, high allergen sensitivity, previous systemic reaction, and injection during an active allergen season. On the basis of findings from several studies, precautions during allergen immunotherapy have been recommended. In addition, several interventions, including premedication with antihistamines or corticosteroids, measurement of peak flow before injection, and access to an antihistamine or injectable epinephrine after an allergen injection, have been suggested as measures to prevent reactions to and improve the safety of allergen immunotherapy. However, additional studies are necessary before these regimens are implemen...Continue Reading

References

Sep 1, 1990·The Journal of Allergy and Clinical Immunology·M J HepnerE B Brown
Apr 1, 1987·The Journal of Allergy and Clinical Immunology·R F LockeyS C Bukantz
Jun 1, 1986·The Journal of Allergy and Clinical Immunology·M A GreenbergR J Summers
Jan 1, 1980·Clinical Allergy·D VervloetJ Charpin
Sep 1, 1993·Allergy Proceedings : the Official Journal of Regional and State Allergy Societies·S M MatloffD K Greineder
Jul 1, 1993·The Journal of Allergy and Clinical Immunology·M J ReidT A Platts-Mills
May 1, 1957·The Journal of Allergy·P P VANARSDEL, W B SHERMAN
Mar 19, 1964·The New England Journal of Medicine·L P JAMES, K F AUSTEN

❮ Previous
Next ❯

Citations

May 10, 2005·Immunology and Allergy Clinics of North America·Mark H Moss
Mar 11, 1998·Current Opinion in Immunology·S K HuangK H Hsieh
Dec 25, 2003·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Kobi SadeShmuel Kivity
Jan 1, 2010·The Libyan Journal of Medicine·Yousef A TaherAntoon J M van Oosterhout
Sep 4, 2014·International Forum of Allergy & Rhinology·Bryan D Leatherman
Aug 12, 2016·International Journal of Immunopathology and Pharmacology·Qianhui QiuHong Han
Jul 14, 2004·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·C BezS Zielen
Jan 6, 2006·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·Z LiuT M Aune

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anaphylaxis

Anaphylaxis is a serious allergic reaction that is rapid in onset and may cause death.

Related Papers

Allergy Proceedings : the Official Journal of Regional and State Allergy Societies
S M MatloffD K Greineder
The Journal of Allergy and Clinical Immunology
David I BernsteinImmunotherapy Committee, American Academy of Allergy, Asthma and Immunology
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
P Sharkey, J Portnoy
The Journal of Allergy and Clinical Immunology
M A GreenbergR J Summers
Current Opinion in Pulmonary Medicine
E Alvarez-Cuesta, E Gonzélez-Mancebo
© 2022 Meta ULC. All rights reserved